ATE435647T1 - Rutheniumkomplexe zur krebsbehandlung - Google Patents
Rutheniumkomplexe zur krebsbehandlungInfo
- Publication number
- ATE435647T1 ATE435647T1 AT05790998T AT05790998T ATE435647T1 AT E435647 T1 ATE435647 T1 AT E435647T1 AT 05790998 T AT05790998 T AT 05790998T AT 05790998 T AT05790998 T AT 05790998T AT E435647 T1 ATE435647 T1 AT E435647T1
- Authority
- AT
- Austria
- Prior art keywords
- cancer treatment
- ruthenium complexes
- ruthenium compounds
- concerns
- preparation
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical class [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 150000003304 ruthenium compounds Chemical class 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F17/00—Metallocenes
- C07F17/02—Metallocenes of metals of Groups 8, 9 or 10 of the Periodic Table
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0407819A FR2873037B1 (fr) | 2004-07-13 | 2004-07-13 | Methodes et compositions pour le traitement de cancers |
| PCT/FR2005/001814 WO2006016069A1 (fr) | 2004-07-13 | 2005-07-13 | Methodes et compositions pour le traitement de cancers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE435647T1 true ATE435647T1 (de) | 2009-07-15 |
Family
ID=34946740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05790998T ATE435647T1 (de) | 2004-07-13 | 2005-07-13 | Rutheniumkomplexe zur krebsbehandlung |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8193175B2 (de) |
| EP (1) | EP1776103B1 (de) |
| AT (1) | ATE435647T1 (de) |
| DE (1) | DE602005015329D1 (de) |
| ES (1) | ES2329697T3 (de) |
| FR (1) | FR2873037B1 (de) |
| PL (1) | PL1776103T3 (de) |
| WO (1) | WO2006016069A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2947180A1 (fr) * | 2009-06-29 | 2010-12-31 | Univ Strasbourg | Methodes et compositions pour le traitement de cancers |
| WO2012068319A2 (en) * | 2010-11-17 | 2012-05-24 | Niiki Pharma Inc. | Method of treating hematological cancers |
| GB201116057D0 (en) | 2011-09-16 | 2011-11-02 | Univ York | Synthesis and anticancer activity of ruthenium (II) cis-cis-1,3,5-triaminocyclohexane complexes |
| ES2452719B1 (es) * | 2012-10-01 | 2015-01-26 | Universitat De Barcelona | Compuestos antitumorales de rutenio (II) |
| CA2950305C (en) | 2014-06-11 | 2023-03-14 | Board Of Regents, The University Of Texas System | Texaphyrin-pt(iv) conjugates and compositions for use in overcoming platinum resistance |
| WO2020138570A1 (ko) * | 2018-12-28 | 2020-07-02 | 서울대학교 산학협력단 | 신규 루테늄 착화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19612291A1 (de) * | 1996-03-28 | 1997-10-02 | Bernhard K Prof Dr Dr Keppler | Arzneimittelzubereitungen enthaltend tumorhemmend wirkende Ruthenium(III)-Komplexe |
| AU3268500A (en) * | 1999-03-19 | 2000-10-09 | Anormed Inc. | Pharmaceutical compositions comprising metal complexes |
-
2004
- 2004-07-13 FR FR0407819A patent/FR2873037B1/fr not_active Expired - Fee Related
-
2005
- 2005-07-13 PL PL05790998T patent/PL1776103T3/pl unknown
- 2005-07-13 DE DE602005015329T patent/DE602005015329D1/de not_active Expired - Lifetime
- 2005-07-13 AT AT05790998T patent/ATE435647T1/de not_active IP Right Cessation
- 2005-07-13 WO PCT/FR2005/001814 patent/WO2006016069A1/fr not_active Ceased
- 2005-07-13 US US11/631,979 patent/US8193175B2/en not_active Expired - Fee Related
- 2005-07-13 EP EP05790998A patent/EP1776103B1/de not_active Expired - Lifetime
- 2005-07-13 ES ES05790998T patent/ES2329697T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1776103B1 (de) | 2009-07-08 |
| US20080051370A1 (en) | 2008-02-28 |
| FR2873037A1 (fr) | 2006-01-20 |
| FR2873037B1 (fr) | 2008-04-11 |
| US8193175B2 (en) | 2012-06-05 |
| DE602005015329D1 (de) | 2009-08-20 |
| PL1776103T3 (pl) | 2009-12-31 |
| EP1776103A1 (de) | 2007-04-25 |
| WO2006016069A1 (fr) | 2006-02-16 |
| ES2329697T3 (es) | 2009-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL258880A (en) | Diarylhydantoin compounds | |
| SG160412A1 (en) | Anti-igfr1 antibody therapeutic combinations | |
| TW200716141A (en) | Compositions and methods for treatment for neoplasms | |
| BRPI0611670A2 (pt) | método para o tratamento ou prevenção de câncer em um indivíduo | |
| IL184617A0 (en) | Dr5 antibodies and uses thereof | |
| SG164368A1 (en) | Treatment of cancer | |
| WO2007061874A3 (en) | Methods and compositions for use in treating cancer | |
| GB2430935A (en) | Tetrapeptide analogs | |
| WO2006107451A3 (en) | Honokiol derivatives for the treatment of proliferative disorders | |
| MX2007011545A (es) | Combinaciones para el tratamiento de cancer que comprenden el anticuerpo anti-egfr e inhibidores de vegfr. | |
| WO2006113483A3 (en) | Methods and compositions for treating or preventing cancer | |
| TW200716088A (en) | Formulations and methods for treating amyloidosis | |
| WO2005085188A3 (en) | Compounds and methods for anti-tumor therapy | |
| ATE435647T1 (de) | Rutheniumkomplexe zur krebsbehandlung | |
| WO2007033167A3 (en) | Compositions and methods for detecting and treating cancer | |
| BRPI0607285A2 (pt) | tratamento de tumores com metástases | |
| EA200971067A1 (ru) | Триазолиламинопиримидиновые соединения | |
| ATE445408T1 (de) | Verwendung von prolactin in der prophylaktischen krebstherapie | |
| TW200738236A (en) | Certain chemical entities, compositions, and methods | |
| TW200714284A (en) | Novel method | |
| TW200640948A (en) | DR5 antibodies and uses thereof | |
| UA101379C2 (en) | Amidophenoxyindazoles useful in the treatment of cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |